Skip to main content
Joseph Mmwa LogoJOSEPH MMWA

If it's health, it's here

Ghana Moves Closer to Ending Malaria

The country reported 52 malaria deaths in 2025, down from 3,259 in 2011, a 98% reduction

Updated on 5 min readAfricaGhana
WhatsApp Image 2026 10 21 at 14.22.43

Only about 52 people in Ghana are thought to have died of malaria in 2025, according to figures from the Ghana Health Service.

That is a 98% fall since 2011.

In April, Dr Nana Yaw Peprah, Deputy Programme Manager of Ghana's National Malaria Elimination Programme, told journalists that a malaria free Ghana was "within reach", VaccinesWork reported on 14 October 2026.

The Ghana Health Service puts the drop at 3,259 deaths in 2011 to 52 in 2025, which means that for every 100 people who died of malaria in 2011, about two died in 2025.

The National Malaria Elimination Programme presented the figures at a press briefing in Accra, the capital, on 23 April 2026, ahead of World Malaria Day.

From 28% to 8.6%

The programme's data show malaria risk falling from 28% in 2011 to about 8.6% now, the Ghana News Agency reported from the briefing.

Transmission continues across the country, with differences between regions.

Greater Accra, the region that includes the capital, has the lowest rate at about 2%, while other regions report higher levels.

Children under five and pregnant women remain the most vulnerable groups.

Dr Elisabeth Tabitha Abbew, head of the infectious diseases department at Cape Coast Teaching Hospital in southern Ghana, told VaccinesWork that her hospital has not recorded a patient whose death was caused by malaria in the last two years.

VaccinesWork is the news site of Gavi, the Vaccine Alliance, which helps pay for vaccines in poorer countries, and the interview was part of a report by Claudia Lacave.

Dr Abbew said a few patients who died there did have the malaria parasite in their blood, but malaria was not the main cause of death.

Deaths down, cases still high

In 2024, Ghana recorded about 4.3 million confirmed malaria cases out of more than 12 million suspected cases, according to the programme's data.

Dr Peprah said testing in health facilities has reached nearly 99%, but fewer than half of suspected cases were confirmed as malaria.

The Ghana News Agency reported that this indicates many fevers are still being wrongly classified as malaria.

How far each tool reaches

The programme gave coverage figures for several tools:

  • Seasonal preventive medicine, given to children during the high risk months, reached about 92% of targeted children, and most completed the full doses.
  • About 89% of pregnant women received at least one dose of preventive treatment, though completion of later doses remains low.
  • Nets treated with insecticide reached about 87% of the target in mass distribution and 85% through health facilities and schools.
  • Malaria vaccine uptake stands at about 75% for first doses and about 60% for later doses.

Dr Franklin Asiedu-Bekoe, Director of the Ghana Health Service's Public Health Division, named underuse of nets, despite wide distribution, as a major challenge.

Dr Emmanuel Boateng, head of diagnostics and treatment at the programme, told VaccinesWork that the vaccine pilot reached children who were not using nets.

What the vaccine study found

Ghana began giving the malaria vaccine in 2019 in a pilot that also included Kenya and Malawi.

The Ghana Health Service says two vaccines, RTS,S and R21, are now part of routine child immunisation.

A study in The Lancet in May 2026 compared areas that introduced the vaccine in 2019 with areas that waited.

Among children old enough to have had three doses, deaths from any cause other than injuries were 13% lower where the vaccine was used, about one in eight deaths prevented.

The study did not measure malaria deaths alone and covered all three countries.

About four in 10 children had received the fourth dose by 2022.

The study was funded by the World Health Organization (WHO), Gavi, the Global Fund and Unitaid.

A medicine made for the youngest

On 24 April 2026, WHO prequalified Coartem Baby, confirming that it meets international standards for quality, safety and efficacy.

It is the first malaria treatment designed for newborns and young infants weighing between two and five kilograms.

WHO said infants had until now been treated with medicines intended for older children, which carry a higher risk of dosing errors, side effects and toxicity.

Its maker, Novartis, said it has already introduced the treatment in Ghana.

Twenty one districts by 2028

Ghana has grouped all its districts by malaria burden and identified 21 low transmission districts for targeted elimination between 2024 and 2028, the programme said.

It aims to cut malaria deaths by 90% and overall cases by 50% over that period.

VaccinesWork described the 21 districts as being in the capital, and reported that only three met their target in 2024 and one area did in 2025.

Elimination means stopping the disease from spreading inside a place, which is different from wiping it out across the whole world.

The funding gap

Dr Peprah said funding constraints are limiting the expansion of key measures, including indoor spraying of homes and preventive treatment programmes.

Dr Asiedu-Bekoe cited limited funding and weak community compliance as risks to progress.

"Every malaria death is preventable," he said, according to the Ghana News Agency.

Ghana against the global picture

WHO's World malaria report 2025 estimated 282 million cases and 610,000 deaths worldwide in 2024, about 9 million more cases than the year before.

About 95% of the deaths were in the WHO African Region, mostly in children under five.

WHO said funding of US$3.9 billion in 2024 reached less than half of the US$9.3 billion target, and listed drug resistance, insecticide resistance and cuts to international aid among the threats.

Ghana's reported deaths moved the other way over 2011 to 2025.

What other African countries could study

As described in the programme's data and the reporting, Ghana's approach has five features.

It sorts districts by malaria burden and sets targets for the lowest burden ones. It uses nets, preventive medicine, vaccines, testing and treatment together.

It measures how many people complete each course, not only how many start.

It has added vaccines to routine immunisation.

And it has introduced a treatment made for the youngest babies.

The reporting does not say these results would be repeated elsewhere.

Kenya and Malawi took part in the same vaccine pilot.

JosephMmwa.com contacted the Ghana Health Service for comment on the figures and programme details in this report, and for any updated data.

The Service had not responded by the time of publication.

The mortality figures cited here were reported by the Service in April 2026.

View sources
Portrait of Joseph Mmwa, health journalistJoseph MmwaHealth & Medical Journalist

Share this story

Never miss health news that matters

Create a free account to follow stories shaping health in Kenya, Africa and around the world.

Comments

Be the first to comment.

Related Stories

Newsletter

The MMWA Briefing

Stay ahead of the health news shaping Kenya, Africa and the world. Get the week's most important developments, research and public-health stories — explained clearly and delivered to your inbox.